Current Studies / MissionAD
Do you qualify to take part in our studies?
Take our pre-screening survey.
Feel your memory isn’t what it used to be?
Many people find their memory changes as they get older. You might forget people’s names or have words on the tip of your tongue that you can’t quite remember. You might feel a little absentminded, such as misplacing your keys or glasses or forgetting why you walked into a room. For most people, these changes are a normal and natural part of ageing. But in some cases, these changes are signs of something more serious — Alzheimer’s disease.
The MissionAD study programme is a clinical research programme testing an investigational drug for the early stages of Alzheimer’s disease. (“Investigational” means the drug isn’t yet approved for use by the public.) Doctors are studying this investigational drug to make sure it is safe and to see if it may help people with Alzheimer’s disease in the future.
People who qualify for this research study may receive:
- Investigational drug
- Study-related care from a local study doctor
- Reimbursement for travel expenses
To qualify for this study, you must:
- Be 50 to 85 years of age
- Be experiencing noticeable changes in memory or thinking
- Have a regular informant/study partner available Doctors will also check other requirements to confirm that you qualify for this study.